Logo image of CROX

CROCS INC (CROX) Stock Fundamental Analysis

NASDAQ:CROX - Nasdaq - US2270461096 - Common Stock - Currency: USD

90.72  +2.05 (+2.31%)

After market: 90.8 +0.08 (+0.09%)

Fundamental Rating

7

Taking everything into account, CROX scores 7 out of 10 in our fundamental rating. CROX was compared to 50 industry peers in the Textiles, Apparel & Luxury Goods industry. CROX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CROX is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, CROX could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year CROX was profitable.
In the past year CROX had a positive cash flow from operations.
Each year in the past 5 years CROX has been profitable.
Each year in the past 5 years CROX had a positive operating cash flow.
CROX Yearly Net Income VS EBIT VS OCF VS FCFCROX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

CROX has a Return On Assets of 19.74%. This is amongst the best in the industry. CROX outperforms 92.00% of its industry peers.
CROX has a Return On Equity of 51.75%. This is amongst the best in the industry. CROX outperforms 94.00% of its industry peers.
CROX has a better Return On Invested Capital (23.23%) than 88.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CROX is significantly above the industry average of 13.61%.
The last Return On Invested Capital (23.23%) for CROX is above the 3 year average (22.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 19.74%
ROE 51.75%
ROIC 23.23%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
CROX Yearly ROA, ROE, ROICCROX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K 5K

1.3 Margins

The Profit Margin of CROX (23.16%) is better than 98.00% of its industry peers.
In the last couple of years the Profit Margin of CROX has grown nicely.
CROX has a Operating Margin of 25.50%. This is amongst the best in the industry. CROX outperforms 98.00% of its industry peers.
In the last couple of years the Operating Margin of CROX has grown nicely.
CROX has a better Gross Margin (58.76%) than 74.00% of its industry peers.
CROX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 25.5%
PM (TTM) 23.16%
GM 58.76%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
CROX Yearly Profit, Operating, Gross MarginsCROX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CROX is creating value.
CROX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CROX has been reduced compared to 5 years ago.
CROX has a better debt/assets ratio than last year.
CROX Yearly Shares OutstandingCROX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CROX Yearly Total Debt VS Total AssetsCROX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CROX has an Altman-Z score of 3.66. This indicates that CROX is financially healthy and has little risk of bankruptcy at the moment.
CROX has a better Altman-Z score (3.66) than 74.00% of its industry peers.
The Debt to FCF ratio of CROX is 1.46, which is an excellent value as it means it would take CROX, only 1.46 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CROX (1.46) is better than 80.00% of its industry peers.
A Debt/Equity ratio of 0.74 indicates that CROX is somewhat dependend on debt financing.
CROX has a Debt to Equity ratio of 0.74. This is in the lower half of the industry: CROX underperforms 66.00% of its industry peers.
Even though the debt/equity ratio score it not favorable for CROX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 1.46
Altman-Z 3.66
ROIC/WACC2.28
WACC10.21%
CROX Yearly LT Debt VS Equity VS FCFCROX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

A Current Ratio of 1.18 indicates that CROX should not have too much problems paying its short term obligations.
CROX's Current ratio of 1.18 is on the low side compared to the rest of the industry. CROX is outperformed by 88.00% of its industry peers.
CROX has a Quick Ratio of 1.18. This is a bad value and indicates that CROX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.70, CROX is not doing good in the industry: 86.00% of the companies in the same industry are doing better.
The current and quick ratio evaluation for CROX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.7
CROX Yearly Current Assets VS Current LiabilitesCROX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

CROX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.31%, which is quite good.
Measured over the past years, CROX shows a very strong growth in Earnings Per Share. The EPS has been growing by 51.64% on average per year.
The Revenue has been growing slightly by 3.53% in the past year.
The Revenue has been growing by 27.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)9.31%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-2.33%
Revenue 1Y (TTM)3.53%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%3.09%

3.2 Future

Based on estimates for the next years, CROX will show a small growth in Earnings Per Share. The EPS will grow by 3.74% on average per year.
Based on estimates for the next years, CROX will show a small growth in Revenue. The Revenue will grow by 3.08% on average per year.
EPS Next Y1.54%
EPS Next 2Y4.24%
EPS Next 3Y2.32%
EPS Next 5Y3.74%
Revenue Next Year2.48%
Revenue Next 2Y3%
Revenue Next 3Y2.51%
Revenue Next 5Y3.08%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CROX Yearly Revenue VS EstimatesCROX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CROX Yearly EPS VS EstimatesCROX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 6.90, the valuation of CROX can be described as very cheap.
CROX's Price/Earnings ratio is rather cheap when compared to the industry. CROX is cheaper than 86.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.29. CROX is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 6.79, which indicates a rather cheap valuation of CROX.
CROX's Price/Forward Earnings ratio is rather cheap when compared to the industry. CROX is cheaper than 90.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.08, CROX is valued rather cheaply.
Industry RankSector Rank
PE 6.9
Fwd PE 6.79
CROX Price Earnings VS Forward Price EarningsCROX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CROX is valued a bit cheaper than the industry average as 78.00% of the companies are valued more expensively.
CROX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CROX is cheaper than 82.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.51
EV/EBITDA 5.61
CROX Per share dataCROX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CROX does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of CROX may justify a higher PE ratio.
PEG (NY)4.47
PEG (5Y)0.13
EPS Next 2Y4.24%
EPS Next 3Y2.32%

0

5. Dividend

5.1 Amount

No dividends for CROX!.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

NASDAQ:CROX (4/17/2025, 8:10:56 PM)

After market: 90.8 +0.08 (+0.09%)

90.72

+2.05 (+2.31%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)02-13 2025-02-13/bmo
Earnings (Next)05-01 2025-05-01/amc
Inst Owners100.85%
Inst Owner Change0%
Ins Owners2.71%
Ins Owner Change5.41%
Market Cap5.09B
Analysts80
Price Target131.28 (44.71%)
Short Float %12.4%
Short Ratio4.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.58%
Min EPS beat(2)9.31%
Max EPS beat(2)13.84%
EPS beat(4)4
Avg EPS beat(4)16.59%
Min EPS beat(4)9.31%
Max EPS beat(4)32.88%
EPS beat(8)8
Avg EPS beat(8)14.13%
EPS beat(12)12
Avg EPS beat(12)15.66%
EPS beat(16)16
Avg EPS beat(16)20.22%
Revenue beat(2)1
Avg Revenue beat(2)0.03%
Min Revenue beat(2)-0.82%
Max Revenue beat(2)0.88%
Revenue beat(4)2
Avg Revenue beat(4)0.83%
Min Revenue beat(4)-1.11%
Max Revenue beat(4)4.37%
Revenue beat(8)4
Avg Revenue beat(8)0.4%
Revenue beat(12)7
Avg Revenue beat(12)0.76%
Revenue beat(16)10
Avg Revenue beat(16)1.73%
PT rev (1m)-0.43%
PT rev (3m)-6.51%
EPS NQ rev (1m)0.26%
EPS NQ rev (3m)-11.23%
EPS NY rev (1m)0.79%
EPS NY rev (3m)0.95%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)-2.85%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-0.49%
Valuation
Industry RankSector Rank
PE 6.9
Fwd PE 6.79
P/S 1.24
P/FCF 5.51
P/OCF 5.12
P/B 2.77
P/tB N/A
EV/EBITDA 5.61
EPS(TTM)13.15
EY14.5%
EPS(NY)13.35
Fwd EY14.72%
FCF(TTM)16.47
FCFY18.15%
OCF(TTM)17.7
OCFY19.51%
SpS73.17
BVpS32.75
TBVpS-11.65
PEG (NY)4.47
PEG (5Y)0.13
Profitability
Industry RankSector Rank
ROA 19.74%
ROE 51.75%
ROCE 25.69%
ROIC 23.23%
ROICexc 24.31%
ROICexgc 67.44%
OM 25.5%
PM (TTM) 23.16%
GM 58.76%
FCFM 22.5%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
ROICexc(3y)23.62%
ROICexc(5y)33.95%
ROICexgc(3y)69.79%
ROICexgc(5y)62.49%
ROCE(3y)24.97%
ROCE(5y)32.97%
ROICexcg growth 3Y-0.46%
ROICexcg growth 5Y13.47%
ROICexc growth 3Y-28.38%
ROICexc growth 5Y-4.85%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
F-Score7
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 1.46
Debt/EBITDA 1.21
Cap/Depr 99.29%
Cap/Sales 1.69%
Interest Coverage 10.52
Cash Conversion 88.95%
Profit Quality 97.17%
Current Ratio 1.18
Quick Ratio 0.7
Altman-Z 3.66
F-Score7
WACC10.21%
ROIC/WACC2.28
Cap/Depr(3y)1933.24%
Cap/Depr(5y)1225.32%
Cap/Sales(3y)21.71%
Cap/Sales(5y)14.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.31%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-2.33%
EPS Next Y1.54%
EPS Next 2Y4.24%
EPS Next 3Y2.32%
EPS Next 5Y3.74%
Revenue 1Y (TTM)3.53%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%3.09%
Revenue Next Year2.48%
Revenue Next 2Y3%
Revenue Next 3Y2.51%
Revenue Next 5Y3.08%
EBIT growth 1Y-0.01%
EBIT growth 3Y14.85%
EBIT growth 5Y52.06%
EBIT Next Year3.6%
EBIT Next 3Y2.04%
EBIT Next 5Y4.44%
FCF growth 1Y13.29%
FCF growth 3Y21.77%
FCF growth 5Y76.83%
OCF growth 1Y6.67%
OCF growth 3Y20.5%
OCF growth 5Y61.62%